CAFC Affirms Dismissal of Arendi’s Second Complaint Against LG After Failure...
On September 7, the U.S. Court of Appeals for the Federal Circuit issued a precedential decision in Arendi S.A.R.L. v. LG Electronics Inc., authored by Circuit Judge Sharon Prost, affirming the...
View ArticleSpotify, SoundCloud and Deezer Music Apps Sued for Infringing Music Organizer...
Patent owner MOAEC Technologies filed suits alleging claims of patent infringement in the District of Delaware against a series of music entertainment app providers including Spotify, SoundCloud and...
View ArticleHatch-Waxman Litigation: 60 Percent Increase in ANDA Lawsuits from 2016 to 2017
In 2017, U.S. district courts saw a total of 417 patent infringement suits related to ANDA filings made by drugmakers with the U.S. Food and Drug Administration (FDA) seeking to bring generic versions...
View ArticleECCO Accuses Skechers of Stealing Soles, Files Patent Infringement Lawsuit in...
Recently, Denmark-based footwear maker ECCO filed a suit alleging claims of patent infringement against Manhattan Beach, CA-based shoemaker Skechers. The suit, filed in the federal district for...
View ArticlePatent Litigation Shows Shift Towards Delaware, Decrease in High-Volume...
Legal data analytics provider Lex Machina recently published a post featuring data points regarding the filing of patent infringement cases in the year following the U.S. Supreme Court’s decision in TC...
View ArticleApple and Samsung Settle Patent Dispute Proving Patent Litigation Doesn’t...
On Wednesday, June 27th, a pair of orders of dismissal, one entered in the District of Delaware and the other entered in the Northern District of California, marked the official end of the patent war...
View ArticleNasal Spray Patents Covering Migraine Drug Zomig Not Invalid As Obvious
The sole question on appeal was whether it would have been obvious to make zolmitriptan into a nasal spray. The Federal Circuit agreed with the district court that the prior art taught away from...
View ArticleCAFC says District Court Erred in Claim Construction in Blackbird Patent Case
On Monday, July 16th, the Court of Appeals for the Federal Circuit issued a precedential decision in Blackbird Tech v. ELB Electronics, which vacated an earlier judgment of non-infringement of a patent...
View ArticleIBM Wins $82.5 Million Award Against Groupon in Jury Verdict
On July 27th, a jury verdict entered into the District of Delaware awarded $82.5 million in reasonable royalties to information technology giant IBM after that company asserted a series of patents...
View ArticleCAFC vacates Summary Judgment entered against Intellectual Ventures
On Tuesday, September 4th, the Court of Appeals for the Federal Circuit issued a precedential decision in Intellectual Ventures I LLC v. T-Mobile USA, Inc., et. al., vacating and remanding a grant of...
View ArticleDelaware Jury Awards $24 Million Royalty to Bio-Rad and University of...
A jury in the United Stated Federal District Court for the District of Delaware recently delivered a verdict awarding nearly $24 million dollars in reasonable royalty damages to plaintiffs Bio-Rad...
View ArticleCAFC Overturns Preliminary Injunction on Generic Suboxone Film Over Newman...
The Federal Circuit issued a nonprecedential decision in Indivior Inc. v. Dr. Reddy’s Laboratories, S.A., which vacated a preliminary injunction handed out by the District of New Jersey in a...
View ArticleHospira Patent Claims that Previously Survived IPR Held Invalid
While the claims-in-suit had previously survived validity challenges in an inter partes review (IPR) proceeding at the Patent Trial and Appeal Board (PTAB) and in a District of Delaware case, Aly...
View ArticleDistrict Court Upholds Orexo Patent for Opioid Dependency Treatment Over...
On January 10, the U.S. District of Delaware held that Actavis’ generic version of Orexo’s opioid dependency treatment infringed an Orexo patent. The patent-at-issue in this order was U.S. Patent No....
View ArticleDistrict of Delaware Makes it Harder to Corner the Market on Antibody Patents...
Patents covering an antibody are often claimed by the antibody’s function (the residues where it binds to the antigen) rather than its structure (amino-acid sequence). This tactic can successfully cast...
View Article
